Gehring R, Baynes R E, Riviere J E
College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA.
J Vet Pharmacol Ther. 2006 Feb;29(1):5-14. doi: 10.1111/j.1365-2885.2006.00707.x.
A risk assessment of the food safety implications of drugs used in food-producing animals is an essential component of the regulatory approval process for products containing these drugs. This ensures that there is negligible risk to human health if these drugs are used according to the instructions that appear on the approved label. A relative paucity of approved products for veterinary species; however, forces veterinarians worldwide to use drugs in an extralabel manner to treat disease and alleviate suffering in animals. In food-producing animals, this may result in residues that are potentially harmful to the human consumer. This review describes how risk assessment principles can be extended to evaluate the risks posed by different classes of extralabel drug use. Risk management practices in the United States and Europe are summarized and contrasted to illustrate the application of these principles.
对用于食用动物的药物所涉及的食品安全影响进行风险评估,是含有这些药物的产品监管审批过程的重要组成部分。这确保了如果按照批准标签上出现的说明使用这些药物,对人类健康的风险可忽略不计。然而,兽用批准产品相对较少,这迫使全球兽医以超标签方式使用药物来治疗动物疾病和减轻动物痛苦。在食用动物中,这可能导致对人类消费者有潜在危害的残留。本综述描述了如何扩展风险评估原则以评估不同类别超标签用药所带来的风险。总结并对比了美国和欧洲的风险管理实践,以说明这些原则的应用。